Literature DB >> 26898127

Carcinoembryonic antigen related cellular adhesion molecule 1 alleviates dextran sulfate sodium-induced ulcerative colitis in mice.

Yu Jin1, Yan Lin1, Lianjie Lin1, Yan Sun1, Changqing Zheng2.   

Abstract

AIMS: To investigate the effects of exogenous carcinoembryonic antigen related cellular adhesion molecule 1 (CEACAM1) on ulcerative colitis (UC) in a dextran sulfate sodium (DSS)-induced mouse model. MAIN
METHODS: UC mice model was induced by administration of DSS in drinking water for 7days. Treatment of CEACAM1 was performed by a transrectal injection of CEACAM1 gene packed adenovirus in the mice. The severity of UC was evaluated using disease activity index and colon length. Histological changes were observed after hematoxylin and eosin staining. ELISA was used to measure secretion of pro-inflammatory cytokines in the colon tissue. The expression of mRNA and protein were detected using real-time PCR and western blotting. The effect of CEACAM1 on epithelial cell restitution was evaluated using wound-healing test in Caco-2 cells. KEY
FINDINGS: CEACAM1 overexpression attenuated the symptoms of UC as evidenced by decreased DAI score, increased colon length and histopathologic score. In addition, exogenous CEACAM1 reduced the levels of inflammatory cytokines and downregulated COX-2 and iNOS expression levels. Moreover, CEACAM1 overexpression decreased colonic permeability by upregulating expression of tight junction proteins. In the in vitro study, exogenous CEACAM1 promoted proliferation and migration of Caco-2 cell. SIGNIFICANCE: Exogenous CEACAM1 effectively rescues the symptoms of UC in DSS mice through preventing inflammatory responses, improving epithelial barrier and promoting epithelial cells restitution.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CEACAM1; Colonic permeability; Epithelial cells restitution; Inflammation; Tight junction; Ulcerative colitis

Mesh:

Substances:

Year:  2016        PMID: 26898127     DOI: 10.1016/j.lfs.2016.02.065

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  CEACAM1 regulates CD8+ T cell immunity and protects from severe pathology during Citrobacter rodentium induced colitis.

Authors:  Julia Zöller; Jana-Fabienne Ebel; Vishal Khairnar; Verena Schmitt; Robert Klopfleisch; Jana Meiners; Virginia Seiffart; Wiebke Hansen; Jan Buer; Bernhard B Singer; Karl S Lang; Astrid M Westendorf
Journal:  Gut Microbes       Date:  2020-06-10

Review 2.  CEACAM1 structure and function in immunity and its therapeutic implications.

Authors:  Walter M Kim; Yu-Hwa Huang; Amit Gandhi; Richard S Blumberg
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

Review 3.  CEACAM1 as a multi-purpose target for cancer immunotherapy.

Authors:  Matthew Dankner; Scott D Gray-Owen; Yu-Hwa Huang; Richard S Blumberg; Nicole Beauchemin
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

4.  Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells.

Authors:  Esther Klaile; Mario M Müller; Miriam R Schäfer; Ann-Katrin Clauder; Sabina Feer; Kerstin A Heyl; Magdalena Stock; Tilman E Klassert; Peter F Zipfel; Bernhard B Singer; Hortense Slevogt
Journal:  mBio       Date:  2017-03-14       Impact factor: 7.867

Review 5.  Inhibitory pattern recognition receptors.

Authors:  Matevž Rumpret; Helen J von Richthofen; Victor Peperzak; Linde Meyaard
Journal:  J Exp Med       Date:  2021-12-14       Impact factor: 17.579

6.  Bachu Mushroom Polysaccharide Alleviates Colonic Injury by Modulating the Gut Microbiota.

Authors:  Zumrat Abdureyim; Lei Wang; Qing Tao; Jing Xu; Delixiati Yimiti; Qian Gao
Journal:  Comput Math Methods Med       Date:  2022-03-14       Impact factor: 2.238

7.  Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis.

Authors:  Keng-Liang Wu; Eng-Yen Huang; Wen-Ling Yeh; Chang-Chun Hsiao; Chung-Mou Kuo
Journal:  Oncotarget       Date:  2017-06-27

8.  Farrerol Ameliorates TNBS-Induced Colonic Inflammation by Inhibiting ERK1/2, JNK1/2, and NF-κB Signaling Pathway.

Authors:  Xin Ran; Yuhang Li; Guangxin Chen; Shoupeng Fu; Dewei He; Bingxu Huang; Libin Wei; Yuanqing Lin; Yingcheng Guo; Guiqiu Hu
Journal:  Int J Mol Sci       Date:  2018-07-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.